Acquired
Novo Nordisk (Ozempic)
David Rosenthal
The naturally occurring GLP-1 analog. Yes. As opposed to the engineered liraglutide. It actually does become a drug candidate. They license it to Eli Lilly. Eli Lilly develops it into Bayeta and Bayeta hits the market in 2005. It's FDA approved and it works. It's not poisonous. It doesn't kill people. And it is the world's first GLP-1 analog to come to market.
0
💬
0
Comments
Log in to comment.
There are no comments yet.